Study to Evaluate the Efficacy and Safety of Dexketoprofen / Butylscopolamine vs Dexketoprofen in Treatment of Primary Dysmenorrhea
brief summary
This study seeks to evaluate the efficacy and safety of the fixed dose combination of dexketoprofen/butylscopolamine compared to dexketoprofen for the treatment of primary dysmenorrhea in 130 mexican women.
detailed description
The primary efficacy endpoint of this study was the assessment of intervention efficacy regarding pain intensity-measured via visual analogue scale (VAS) at 30 minutes and at 1, 2, 4, 6, 8, 24, 48, and 72 hours-to determine whether treatment with dexketoprofen/butylscopolamine resulted in a greater reduction in pain than dexketoprofen monotherapy. The primary safety endpoint involved describing, classifying, and comparing adverse events occurring during the study across treatment arms, based on their gravity, frequency, severity, and causality.
official title
A Phase III, Parallel-group Study to Evaluate the Efficacy and Safety of the Fixed-dose Combination of Dexketoprofen/Butylscopolamine Compared With Dexketoprofen Monotherapy in the Treatment of Primary Dysmenorrhea